Keyword: Clovis Oncology

Gritstone Oncology

Gristone Oncology, a biotech-medtech crossover, is working to apply next-generation sequencing, bioinformatics and algorithms to the creation of new cancer immunotherapies.
breast cancer

21. Rubraca

With an accelerated approval ahead of its February 2017 PDUFA date, Clovis Oncology’s Rubraca is set to launch and challenge AstraZeneca’s Lynparza.